A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Global Clinical Compliance
Ferring Pharmaceuticals
Study Director - John Alexander, MD, MHS
Division of Cardiovascular Medicine, Duke Clinical Research Institute
Principal Investigator - Susan Slovin, MD
Sidney Kimmel Center for Urologic and Prostate Cancers, Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
133 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Male Health Centre Euroscope Inc
Barrie, Ontario, Canada
- J. Giddens Medicine Professional Corporation
Brampton, Ontario, Canada
- G. Kenneth Jansz Medicine Professional Corporation
Burlington, Ontario, Canada
- Urology Associates Urologic Medical Research
Kitchener, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Femalemale Health Centres
Oakville, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Uro Laval
Laval, Quebec, Canada
- Jewish General Hospital / Mcgill University
Montreal, Quebec, Canada
- Chu de Québec -Hôtel-Dieu de Québec
Québec, Canada
- Fakultni Nemocnice Olomouc
Olomouc, Czechia
- Fakultni Nemocnice Ostrava
Ostrava, Czechia
- Multiscan S.R.O.
Pardubice, Czechia
- Urocentrum Plzen
Pilsen, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Proton Therapy Center Czech S.R.O.
Prague, Czechia
- Oblastni Nemocnice Pribram A.S.
Příbram, Czechia
- Krajska Zdravotni A.S. - Masarykova Nemocnice V Usti Nad Labem O.Z.
Ústí nad Labem, Czechia
- Keski-Suomen Keskussairaala
Jyväskylä, Finland
- Tampereen Yliopistollinen
Tampere, Finland
- Institut Sainte Catherine
Avignon, France
- Groupe Hospitalier Pellegrin Tripode
Bordeaux, France
- Hôpital Henri Mondor
Créteil, France
- Chu de Grenoble - Hôpital Albert Michallon
Grenoble, France
- Ch de Libourne- Hopital Robert Boulin
Libourne, France
- Hopital Claude Huriez - Chu Lille
Lille, France
- Hopital Edouard Herriot - Chu Lyon
Lyon, France
- Centre Hospitalier Régional Universitaire de Tours
Nantes, France
- Hopital Bichat - Claude Bernard
Paris, France
- Clinique Saint Jean Languedoc
Toulouse, France
- Universitaetsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Urologische Gemeinschaftspraxis
Kirchheim unter Teck, Baden-Wurttemberg, Germany
- Urologische Gemeinschaftspraxis
Herzogenaurach, Bavaria, Germany
- Staedtisches Klinikum Braunschweig Gmbh - Standort Salzdahlumer
Braunschweig, Lower Saxony, Germany
- Klinikum Oldenburg Ggmbh
Oldenburg, Lower Saxony, Germany
- Kliniken Maria Hilf Gmbh
Mönchengladbach, North Rhine-Westphalia, Germany
- Praxisklinik Urologie Rhein Ruhr
Mülheim, North Rhine-Westphalia, Germany
- Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt
Dresden, Saxony, Germany
- Urologie Am Nordplatz
Leipzig, Saxony, Germany
- Facharztpraxis Für Urologie
Eisleben Lutherstadt, Saxony-Anhalt, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2016
- Primary completion
- 29 Mar 2021
- Completion
- 29 Mar 2021
- Last update posted
- 29 Jun 2022
- Registered enrollment
- 545
- Registry id
- NCT02663908
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.